ZA200800328B - Ethanolamine salt on N-(3-methoxy-5-methylpyrazin-2yl)-2-(4-[1,3,4-oxadiazole-2-yl]phenyl)pyridine-3-sulphonamide - Google Patents

Ethanolamine salt on N-(3-methoxy-5-methylpyrazin-2yl)-2-(4-[1,3,4-oxadiazole-2-yl]phenyl)pyridine-3-sulphonamide

Info

Publication number
ZA200800328B
ZA200800328B ZA200800328A ZA200800328A ZA200800328B ZA 200800328 B ZA200800328 B ZA 200800328B ZA 200800328 A ZA200800328 A ZA 200800328A ZA 200800328 A ZA200800328 A ZA 200800328A ZA 200800328 B ZA200800328 B ZA 200800328B
Authority
ZA
South Africa
Prior art keywords
methylpyrazin
sulphonamide
pyridine
methoxy
phenyl
Prior art date
Application number
ZA200800328A
Other languages
English (en)
Inventor
Good Catherine
Montgomery Frank
Hogan Philip John
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200800328B publication Critical patent/ZA200800328B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA200800328A 2005-07-19 2008-01-10 Ethanolamine salt on N-(3-methoxy-5-methylpyrazin-2yl)-2-(4-[1,3,4-oxadiazole-2-yl]phenyl)pyridine-3-sulphonamide ZA200800328B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0514743.4A GB0514743D0 (en) 2005-07-19 2005-07-19 Salt

Publications (1)

Publication Number Publication Date
ZA200800328B true ZA200800328B (en) 2008-12-31

Family

ID=34897419

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200800328A ZA200800328B (en) 2005-07-19 2008-01-10 Ethanolamine salt on N-(3-methoxy-5-methylpyrazin-2yl)-2-(4-[1,3,4-oxadiazole-2-yl]phenyl)pyridine-3-sulphonamide

Country Status (23)

Country Link
US (2) US20080221124A1 (xx)
EP (1) EP1904490B1 (xx)
JP (1) JP5085544B2 (xx)
KR (1) KR20080031042A (xx)
CN (1) CN101223165B (xx)
AT (1) ATE482952T1 (xx)
AU (1) AU2006271420B2 (xx)
CA (1) CA2615596A1 (xx)
CY (1) CY1110942T1 (xx)
DE (1) DE602006017220D1 (xx)
DK (1) DK1904490T3 (xx)
ES (1) ES2351442T3 (xx)
GB (1) GB0514743D0 (xx)
HK (1) HK1118276A1 (xx)
HR (1) HRP20100621T1 (xx)
IL (1) IL188389A0 (xx)
MX (1) MX2008000889A (xx)
NO (1) NO20080053L (xx)
PL (1) PL1904490T3 (xx)
PT (1) PT1904490E (xx)
SI (1) SI1904490T1 (xx)
WO (1) WO2007010235A1 (xx)
ZA (1) ZA200800328B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0219660D0 (en) 2002-08-23 2002-10-02 Astrazeneca Ab Therapeutic use
GB0403744D0 (en) 2004-02-20 2004-03-24 Astrazeneca Ab Chemical process
GB0914287D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Compositions
CN102491973A (zh) * 2011-12-15 2012-06-13 南京友杰医药科技有限公司 Zd-4054的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514691A (en) * 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5464853A (en) * 1993-05-20 1995-11-07 Immunopharmaceutics, Inc. N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
UA58494C2 (uk) * 1995-06-07 2003-08-15 Зенека Лімітед Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну
US20020055457A1 (en) * 2000-08-07 2002-05-09 Janus Todd J. Methods of treating cancer and the pain associated therewith using endothelin antagonists
US20030092757A1 (en) * 2001-04-11 2003-05-15 Amitabh Singh Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen
WO2003051870A1 (en) * 2001-12-18 2003-06-26 Astrazeneca Ab Novel compounds
GB0219660D0 (en) * 2002-08-23 2002-10-02 Astrazeneca Ab Therapeutic use

Also Published As

Publication number Publication date
HRP20100621T1 (hr) 2010-12-31
CA2615596A1 (en) 2007-01-25
KR20080031042A (ko) 2008-04-07
ES2351442T3 (es) 2011-02-04
PT1904490E (pt) 2010-11-18
HK1118276A1 (en) 2009-02-06
US20120101109A1 (en) 2012-04-26
AU2006271420A1 (en) 2007-01-25
DE602006017220D1 (de) 2010-11-11
ATE482952T1 (de) 2010-10-15
EP1904490B1 (en) 2010-09-29
WO2007010235A1 (en) 2007-01-25
JP5085544B2 (ja) 2012-11-28
SI1904490T1 (sl) 2010-12-31
DK1904490T3 (da) 2010-12-13
CN101223165B (zh) 2011-10-19
EP1904490A1 (en) 2008-04-02
CN101223165A (zh) 2008-07-16
MX2008000889A (es) 2008-03-18
US20080221124A1 (en) 2008-09-11
CY1110942T1 (el) 2015-06-10
GB0514743D0 (en) 2005-08-24
WO2007010235A8 (en) 2008-03-13
IL188389A0 (en) 2008-04-13
AU2006271420B2 (en) 2010-09-23
JP2009501774A (ja) 2009-01-22
PL1904490T3 (pl) 2011-02-28
NO20080053L (no) 2008-04-16

Similar Documents

Publication Publication Date Title
HRP20090229T1 (en) Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl] phenyl)pyridine-3-sulphonamide and a biphosphonate
EA201000888A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы в качестве гербицидов
EA201000145A1 (ru) Кристаллические формы 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино)бензамида
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
ECSP056229A (es) Una composición farmacéutica que comprende formas polimórficas de 3-(4-amino-1-oxo-1.3 dyhidro-isoindol-2-il)-piperidina-2,6-diona para el tratamiento y manejo de cánceres
ATE525913T2 (de) Fettzusammensetzungen
IL185002A0 (en) Sphingosine 1-phosphate agonists comprising cycloalkanes and 5-membered heterocycles substituted by amino and phenyl groups
EA200701918A1 (ru) Белок липокалин
TW200736195A (en) Methods for preparing sulfonamide substituted alcohols and intermediates thereof
MX2010003989A (es) Composicion zibotentan que contiene mannitol y/o celulosa microcristalina.
CL2011003138A1 (es) N-(protegido- n-(3-metoxi-5-metilpirazon-2-il)-2-(4-[1,3,4-oxadiazol-2-il]fenil)piridino-3-sulfonamida y su proceso de preparacion.
IS7766A (is) N-(3-metoxý-5-metýlpýrasín-2-ýl)-2-(4-[1,3,4-oxadíasól-2-ýl]fenýl)pýridín-3-súlfónamíð sem krabbameinslyf
EA200801413A1 (ru) Гетероциклические сетр ингибиторы
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
ZA200800328B (en) Ethanolamine salt on N-(3-methoxy-5-methylpyrazin-2yl)-2-(4-[1,3,4-oxadiazole-2-yl]phenyl)pyridine-3-sulphonamide
BRPI0500536A (pt) Composição antimicrobiana
MX2007007355A (es) 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor.
UA92592C2 (xx) Комбінація, яка містить n-(3-метокси-5-метилпіразин-2-іл)-2-(4-$1,3,4-оксадіазол-2-іл]феніл)піридин-3-сульфонамід і антимітотичний засіб, яким є таксан, для лікування злоякісного новоутворення$комбинация, которая содержит n-(3-метокси-5-метилпиразин-2-ил)-2-(4-$1,3,4-оксадиазол-2-ил]фенил)пиридин-3-сульфонамид и антимитотическое средство, которым является таксан, для лечения злокачественного новообразования
ZA200706391B (en) Sphingosine 1-phosphate agonists comprising cycloalkanes and 5-membered heterocycles substituted by amino and phenyl groups
BRPI0511183A (pt) metabólitos de (+)-(2s, 3s)-3-(2-metóxi-5-trifluorometoxibenzilamino)-2-fenil- piperidina
BRPI0602502A (pt) composição
UA98676C2 (ru) Композиция зиботентана, содержащая маннит и микрокристаллическую целлюлозу
CL2007002391A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de fibrosis.
UA3387U (uk) Застосування 2-феніл-3-карбетокси-4-диметиламінометил-5-оксибензофурану гідрохлориду (вінборону) як утеролітичного засобу